Payal Fadia, MD
Physical Medicine & Rehabilitation · Decatur, GANPI 1639123136
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $54,120 of the $65,770 with a category attached, or 82.3%. AbbVie accounts for 99.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $20,235 and has fallen 60.7% since, to $7,952 in 2025. Among physical medicine & rehabilitation clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $592.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$65K
- Merz Pharmaceuticals, LLC$233
- Ipsen Biopharmaceuticals, Inc$47
- Revance Therapeutics, Inc.$22
- Amgen$17
- Saol Therapeutics Inc.$13
What the payments were for
- Consulting fees$3,8816%
- Speaking & faculty fees$54,12082%
- Travel & lodging$4,9758%
- Food & beverage$2,7934%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 101 | $65,437 |
| Merz Pharmaceuticals, LLC | 5 | $233 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Revance Therapeutics, Inc. | 1 | $22 |
| Amgen | 1 | $17 |
| Saol Therapeutics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,770 in reported general payments places this provider in the 95th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dantrolene Sodium | 44 | $5,595 |
| Baclofen | 160 | $2,811 |
| Levetiracetam ErLevetiracetam | 12 | $2,002 |
| Gabapentin | 20 | $303 |
| Mirtazapine | 11 | $150 |
| Duloxetine Hcl | 12 | $148 |
| Donepezil Hcl | 17 | $119 |
| Escitalopram Oxalate | 16 | $95 |
| Atorvastatin Calcium | 15 | $86 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $65 |
| Tamsulosin Hcl | 11 | $44 |
| Lisinopril | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Decatur
- Erik ShawAtlanta$175K
- David TranAlpharetta$96K
- John MusserStockbridge$57K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald ChaiLawrenceville$16K
- Gerald BilskyAtlanta$16K
- Aiwane IboayaColumbus$16K
- Joseph HegartyBaxley$12K
- Markus NiederwangerSavannah$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.